Perspective Therapeutics Quote - CATX

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.61

Bid

Offer

Volume

871,216

3.63 Day's Range 3.91

2.70 52 Week Range 19.05

Market Cap

243.991M

Previous Close

3.61

Open

3.65

Last Trade

40682

3.81

Last Trade Time

Financial Volume

US$ 3,288,631

VWAP

3.7748

Average Volume (3m)

1,725,040

Shares Outstanding

67,587,540

Dividend Yield

PE Ratio

-5.54

Earnings Per Share (EPS)

-0.69

Revenue

1.43M

Net Profit

-46.51M

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers incl... Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers including prostate cancer, head and neck, lung and brain. The Company has also developed a lead-212 generator to secure isotope supply for clinical trials and commercial operations. Its lead-212 generator utilizes the isotope lead-212 to deliver alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also engaged in the development of imaging diagnostics (Pb-203 (Lead-203)). The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs are under Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at various academic institutions. Show more

Sector

Eating Places

Industry

Surgical,med Instr,apparatus

Website

perspectivetherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1983

Perspective Therapeutics Inc is listed in the Eating Places sector of the American Stock Exchange with ticker CATX. The last closing price for Perspective Therapeutics was US$3.61. Over the last year, Perspective Therapeutics shares have traded in a share price range of US$ 2.70 to US$ 19.05.

Perspective Therapeutics currently has 67,587,540 shares in issue. The market capitalisation of Perspective Therapeutics is US$243.99 million. Perspective Therapeutics has a price to earnings ratio (PE ratio) of -5.54.

Form 8-K - Current report

Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers Symposium

Updated interim results with an additional 10 weeks of follow-up on the nine patients in Cohorts 1 (2.5 mCi) and Cohort 2 (5.0 mCi) of the ongoing Phase 1/2a study support continuation of...

Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET to be Presented at the ASCO Gastrointestinal Cancers Symposium on January 24, 2025

SEATTLE, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...

Form 8-K - Current report

Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference

Anticipates multiple clinical updates in the next 12-18 months, including further progress from two ongoing clinical programs and initiation of therapeutic dosing of one new asset based on its...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.03	-0.824175824176	3.64	4.24	3.5	1235296	3.82936468	CS
4	0.37	11.4197530864	3.24	4.24	3.02	1145456	3.5252124	CS
12	-8.65	-70.5546492659	12.26	12.42	2.7	1725040	4.10298188	CS
26	-9.33	-72.1020092736	12.94	16.55	2.7	1192283	7.57530609	CS
52	-3.109	-46.2717666319	6.719	19.05	2.7	2583102	12.15509196	CS
156	-0.153	-4.06590486314	3.763	19.05	2.05	1709323	10.45573035	CS
260	-0.153	-4.06590486314	3.763	19.05	2.05	1709323	10.45573035	CS

CATX - Frequently Asked Questions (FAQ)

What is the current Perspective Therapeutics share price?

The current share price of Perspective Therapeutics is US$ 3.61

How many Perspective Therapeutics shares are in issue?

Perspective Therapeutics has 67,587,540 shares in issue

What is the market cap of Perspective Therapeutics?

The market capitalisation of Perspective Therapeutics is USD 243.99M

What is the 1 year trading range for Perspective Therapeutics share price?

Perspective Therapeutics has traded in the range of US$ 2.70 to US$ 19.05 during the past year

What is the PE ratio of Perspective Therapeutics?

The price to earnings ratio of Perspective Therapeutics is -5.54

What is the cash to sales ratio of Perspective Therapeutics?

The cash to sales ratio of Perspective Therapeutics is 179.72

What is the reporting currency for Perspective Therapeutics?

Perspective Therapeutics reports financial results in USD

What is the latest annual turnover for Perspective Therapeutics?

The latest annual turnover of Perspective Therapeutics is USD 1.43M

What is the latest annual profit for Perspective Therapeutics?

The latest annual profit of Perspective Therapeutics is USD -46.51M

What is the registered address of Perspective Therapeutics?

The registered address for Perspective Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Perspective Therapeutics website address?

The website address for Perspective Therapeutics is perspectivetherapeutics.com

Which industry sector does Perspective Therapeutics operate in?

Perspective Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FOXOFOXO Technologies Inc	US$ 0.2553 (14.28%)	6.54M
RIOXDefiance Daily Target 2x Long Riot ETF	US$ 23.44 (11.30%)	216.07k
AUSTAustin Gold Corp	US$ 1.31 (11.02%)	401.21k
CHROChannel Therapeutics Corporation	US$ 2.44 (10.91%)	121.02k
ZONECleanCore Solutions Inc	US$ 1.0762 (9.82%)	39.76k
SGNSigning Day Sports Inc	US$ 2.56 (-41.01%)	3.09M
EXODExodus Movement Inc	US$ 58.96 (-33.98%)	204.24k
DXFEason Technology Limited	US$ 16.53 (-28.04%)	216.99k
OSTXOS Therapies Incorporated	US$ 1.95 (-23.53%)	745.08k
PMNTPerfect Moment Ltd	US$ 0.69 (-18.83%)	113.81k
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2.3599 (-6.17%)	120.13M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 27.15 (5.72%)	87.14M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3.32 (-1.19%)	81.2M
FXIiShares China Large Cap	US$ 32.59 (2.39%)	66.77M
XLFFinancial Select Sector	US$ 51.77 (0.96%)	63.74M